Skip to main content
Premium Trial:

Request an Annual Quote

Caliper, Carestream Settle Patent Infringement Lawsuits

NEW YORK (GenomeWeb News) – Caliper Life Sciences today announced a settlement with Carestream Health, ending a legal dispute over imaging technologies.

The announcement puts an end to two lawsuits Caliper and Carestream filed against each other alleging patent infringement. In the first lawsuit, filed in February 2010, Caliper sued Carestream alleging the Rochester, NY-based firm's Kodak in vivo molecular imaging systems infringed seven patents owned by Stanford University and exclusively licensed to Caliper subsidiary Xenogen.

In July 2010, Carestream filed a countersuit alleging that Caliper's Lumina XR system infringed a patent issued to Carestream a month earlier.

As part of the settlement, Caliper and Carestream have agreed to dismiss all claims and counterclaims, and Carestream will not market or sell in vivo optical imaging systems for certain applications covered by the Stanford patents licensed to Xenogen and Caliper.

Carestream also will not assert that the Lumina XR system as currently configured infringes any of its patents.

Financial terms of the settlement were not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.